• Parexel partnered with Weave Bio to launch an AI-enabled workflow for New Drug Application submissions.
• Parexel’s use of Weave platform in live NDA work cut authoring timelines by more than 60% versus traditional methods.
• Collaboration expanded Weave platform with NDA-scale collaboration features, automated data extraction, authoring, verification, workflow tools.
• Weave added new NDA templates available to sponsors, while Parexel secured a defined exclusivity period as only CRO with access to co-developed templates.
• NDA support is available now on Weave platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parexel International Corporation published the original content used to generate this news brief on April 29, 2026, and is solely responsible for the information contained therein.